RxDoctor Payments Data

Ana Basso, MD

Obstetrics & Gynecology · Scott Depot, WVNPI 1023096377

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 233 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations.

$4,684in general payments, 2019–2025

Across 233 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$923
  • Daiichi Sankyo Inc.$588
  • Astellas Pharma US Inc$508
  • Mayne Pharma Commercial LLC$317
  • Sumitomo Pharma America, Inc.$270
  • Organon$240
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$4,53297%
  • Education$1523%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,684 in reported general payments places this provider in the 85th percentile of 172 obstetrics & gynecology providers in West Virginia.

See all obstetrics & gynecology providers in West Virginia

Medicare billing

Part B allowed, 2024
$14,878
Medicare patients
76
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol25$1,718
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$190
Medroxyprogesterone Acetate16$157
Fluconazole22$142

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Scott Depot

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →